AmpliTech Gr (NASDAQ:AMPG) reported quarterly sales of $5.40 million which beat the analyst consensus estimate of $4.25 million by 27.06 percent. This is a 410.88 percent increase over sales of $1.06 million the same period last year.
Related Posts
Nurix Therapeutics Q1 EPS $(0.95) Down From $(0.63) YoY, Sales $9.60M Up From $5.01M YoY
Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.95) per share. This is a 50.79 percent decrease over losses of $(0.63) per share from the same period last year. The company reported $9.60 million in
Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5
Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.
Lipocine Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO
Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the U.S. Food and Drug Administration ("FDA") has affirmed the resubmission